Patents by Inventor Guoqiang Wang

Guoqiang Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11371328
    Abstract: The invention discloses an integrated method for nitrogen-assisted carbon dioxide fracturing and development of shale oil reservoirs, comprising the following steps: fracture the target shale reservoir with nitrogen-assisted carbon dioxide; after fracturing, firstly inject carbon dioxide gas into the target shale oil reservoir, and then inject nitrogen gas to push the carbon dioxide gas into the further location of the oil reservoir; shut in the well in the target shale oil reservoir; after shut-in, open the well to implement depletion production; after the first cycle of production, the slug volume of the injected gas and the shut-in time are 1.5 times of those in the previous cycle in the subsequent production, and Steps 5 to 7 are repeated for each cycle.
    Type: Grant
    Filed: December 9, 2021
    Date of Patent: June 28, 2022
    Assignee: Southwest Petroleum University
    Inventors: Xiang Zhou, Qi Jiang, Yongchao Wang, Jie He, Chunsheng Yu, Siyuan Huang, Yang Zhang, Jiali Liu, Fangjie Wu, Guoqiang Tian
  • Patent number: 11370727
    Abstract: A benzene selective hydrogenation reaction system and a method are provided. The system includes a benzene refiner, a first hydrogenation reactor, a second hydrogenation reactor and a separator which are connected in sequence. The first hydrogenation reactor is provided with a first inlet and a first outlet, and the second hydrogenation reactor is provided with a second inlet and a second outlet. The first inlet is connected to the discharge port of the benzene refiner; the first outlet is connected to the second inlet; the second outlet is connected to the separator. The catalyst outlet is connected to the first hydrogenation reactor for recycling the catalyst into the first hydrogenation reactor. Two micro-interface units are respectively disposed within the first hydrogenation reactor and the second hydrogenation reactor, and the micro-interface units are used for dispersing and breaking hydrogen into micro-bubbles with a micron-scale diameter.
    Type: Grant
    Filed: May 28, 2020
    Date of Patent: June 28, 2022
    Assignee: NANJING YANCHANG REACTION TECHNOLOGY RESEARCH INSTITUTE CO., LTD.
    Inventors: Zhibing Zhang, Zheng Zhou, Feng Zhang, Lei Li, Weimin Meng, Baorong Wang, Gaodong Yang, Huaxun Luo, Guoqiang Yang, Hongzhou Tian, Yu Cao
  • Publication number: 20220199650
    Abstract: An array substrate including a display area having a plurality of subpixels is provided. The plurality of subpixels includes a plurality of first subpixels in a display-bonding sub-area and a plurality of second subpixels in a regular display sub-area. The array substrate includes a plurality of thin film transistors on a first side of the base substrate and respectively in the plurality of subpixels. A respective one of the plurality of first subpixels includes a bonding pad on a second side of a base substrate; a lead line electrically connecting a respective one of a plurality of thin film transistors to the bonding pad; and a via extending through the base substrate. The lead line is unexposed in the array substrate. The lead line extends from the first side to the second side of the base substrate through the via, to connect to the bonding pad.
    Type: Application
    Filed: March 24, 2020
    Publication date: June 23, 2022
    Applicant: BOE Technology Group Co., Ltd.
    Inventors: Ke Wang, Muxin Di, Zhiwei Liang, Guoqiang Wang, Renquan Gu, Xiaoxin Song, Xiaoyan Zhu, Yingwei Liu, Zhanfeng Cao
  • Publication number: 20220199862
    Abstract: Embodiments of the present disclosure provide an intermediate substrate, including: a first substrate; a black photoresist layer on a side of the first substrate; and a plurality of light emitting devices on a side of the black photoresist layer away from the first substrate. Each of the plurality of light emitting devices has a light-exiting side for emergence of light emitted by the light emitting device, the light-exiting side is in contact with the black photoresist layer, and the light emitting device includes a driving electrode for introducing a driving signal.
    Type: Application
    Filed: May 28, 2020
    Publication date: June 23, 2022
    Inventors: Zhiwei LIANG, Yingwei LIU, Guoqiang WANG, Muxin DI, Ke WANG, Hsuanwei MAI, Zhanfeng CAO
  • Publication number: 20220186595
    Abstract: The invention discloses an integrated method for nitrogen-assisted carbon dioxide fracturing and development of shale oil reservoirs, comprising the following steps: fracture the target shale reservoir with nitrogen-assisted carbon dioxide; after fracturing, firstly inject carbon dioxide gas into the target shale oil reservoir, and then inject nitrogen gas to push the carbon dioxide gas into the further location of the oil reservoir; shut in the well in the target shale oil reservoir; after shut-in, open the well to implement depletion production; after the first cycle of production, the slug volume of the injected gas and the shut-in time are 1.5 times of those in the previous cycle in the subsequent production, and Steps 5 to 7 are repeated for each cycle.
    Type: Application
    Filed: December 9, 2021
    Publication date: June 16, 2022
    Applicant: Southwest Petroleum University
    Inventors: Xiang ZHOU, Qi JIANG, Yongchao WANG, Jie HE, Chunsheng YU, Siyuan HUANG, Yang ZHANG, Jiali LIU, Fangjie WU, Guoqiang TIAN
  • Patent number: 11358887
    Abstract: The invention provides a treatment system and a treatment method for PMIDA high-salinity wastewater. The treatment system includes a booster pump, a water inlet-outlet heat exchanger, a water inlet heater and an oxidation reactor, and the water inlet-outlet heat exchanger is provided with a wastewater inlet, a wastewater outlet, an oxidized water inlet, and an oxidized water outlet. An oxidized water from the oxidation reactor enters the water inlet-outlet heat exchanger through the oxidized water inlet, the oxidized water outlet is connected to an intermediate tank, the wastewater inlet is connected to the booster pump, and the wastewater outlet is connected to a wastewater heater. A micro-interface unit is disposed at the lower part in the oxidation reactor, for dispersing crushed gas into bubbles. A gas inlet is formed at a side wall of the oxidation reactor and is connected to the micro-interface unit through a pipeline.
    Type: Grant
    Filed: May 27, 2020
    Date of Patent: June 14, 2022
    Assignee: NANJING YANCHANG REACTION TECHNOLOGY RESEARCH INSTITUTE CO., LTD.
    Inventors: Zhibing Zhang, Zheng Zhou, Feng Zhang, Lei Li, Weimin Meng, Baorong Wang, Gaodong Yang, Huaxun Luo, Guoqiang Yang, Hongzhou Tian, Yu Cao
  • Patent number: 11363010
    Abstract: A method and device for managing a digital certificate are provided. A digital certificate requesting device negotiates with a digital certificate issuing device by using an acquired authorization code, to establish a security data channel and generate a security key, and messages can be encrypted with the generated data communication key during a process of message interaction between the digital certificate requesting device and the digital certificate issuing device, thereby effectively increasing the security in data transmission. The method and device are applicable for automatically requesting for, querying, updating, revoking a digital certificate and acquiring a digital certificate revocation list in various scenarios.
    Type: Grant
    Filed: February 13, 2018
    Date of Patent: June 14, 2022
    Assignee: CHINA IWNCOMM CO., LTD.
    Inventors: Yuehui Wang, Bianling Zhang, Manxia Tie, Xiaolong Lai, Qin Li, Weigang Tong, Guoqiang Zhang, Zhiqiang Du, Xiang Yan
  • Publication number: 20220180807
    Abstract: The present disclosure provides a display panel having a display area and including: a plurality of infrared emitting units and a plurality of infrared receiving units in the display area. The plurality of infrared emitting units are configured to emit infrared light to outside of the display panel, and the plurality of infrared receiving units are configured to receive the infrared light reflected by an object outside the display panel and output an electrical signal according to the received infrared light.
    Type: Application
    Filed: February 18, 2021
    Publication date: June 9, 2022
    Inventors: Peng XU, Jianbo YE, Ju MEI, Zhenzhen WANG, Guoqiang MA
  • Patent number: 11352363
    Abstract: The present invention discloses compounds of Formula (Ia), and pharmaceutically acceptable salts, thereof: which inhibit coronavirus replication activity. The invention further relates to pharmaceutical compositions comprising a compound of Formula (Ia) or a pharmaceutically acceptable slat thereof, and methods of treating or preventing a coronavirus infection in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a compound of Formula (Ia) or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: September 20, 2021
    Date of Patent: June 7, 2022
    Assignee: Enanta Pharmaceuticals, Inc.
    Inventors: Guoqiang Wang, Xuri Gao, Ruichao Shen, Yong He, Jiajun Zhang, Joseph D. Panarese, Hui Cao, Xuechao Xing, Yat Sun Or
  • Patent number: 11354928
    Abstract: A photoelectric detection circuit, a photoelectric detection method, an array substrate, a display panel, and a fingerprint image acquisition method are provided. The photoelectric detection circuit includes a pixel circuit and a phototransistor. The pixel circuit includes an infrared light-emitting element and is configured to emit infrared light according to a scanning signal and a light-emitting data signal. The phototransistor is configured to detect the infrared light emitted by the pixel circuit and reflected by a detection object in response to a sampling control signal.
    Type: Grant
    Filed: February 28, 2019
    Date of Patent: June 7, 2022
    Assignees: CHENGDU BOE OPTOELECTRONICS TECHNOLOGY CO., LTD., BOE TECHNOLOGY GROUP CO., LTD.
    Inventors: Guoqiang Tang, Yang Wang, Yingsong Xu
  • Patent number: 11345699
    Abstract: The present invention discloses compounds of Formula (I), and pharmaceutically acceptable salts and esters thereof: which inhibit the Apoptosis signal-regulating kinase 1 (ASK-1), which associated with autoimmune disorders, neurodegenerative disorders, inflammatory diseases, chronic kidney disease, cardiovascular disease. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from ASK-1 related disease. The invention also relates to methods of treating an ASK-1 related disease in a subject by administering a pharmaceutical composition comprising the compounds of the present invention. The present invention specifically relates to methods of treating ASK-1 associated with hepatic steatosis, including non-alcoholic fatty liver disease (NAFLD) and non-alcohol steatohepatitis disease (NASH).
    Type: Grant
    Filed: November 19, 2019
    Date of Patent: May 31, 2022
    Assignee: Enanta Pharmaceuticals, Inc.
    Inventors: Brett Granger, Guoqiang Wang, Ruichao Shen, Jing He, Yong He, Xuechao Xing, Jun Ma, Jiang Long, Bin Wang, Yat Sun Or
  • Patent number: 11345865
    Abstract: The present invention relates to a micro-interface strengthening reaction system and method for heavy oil hydrogenation preparation of ship fuel, including a liquid phase feed unit, a gas phase feed unit, a micro-interface generator, a fixed-bed reactor and a separation tank. The present invention may reduce the pressure during the reaction by 10-80% while ensuring the efficiency of the reaction by breaking the gas to form micro-sized micro-bubbles and making the micro-bubbles mix with heavy oil to form an emulsion to increase the area between the gas and the liquid phase and to achieve the effect of enhancing mass transfer in a lower preset range. And, the present invention greatly enhances the mass transfer, so that the gas-liquid ratio can be greatly reduced. Also, the method of the present invention has low process severity, high production safety, low product cost per ton, and strong market competitiveness.
    Type: Grant
    Filed: June 6, 2019
    Date of Patent: May 31, 2022
    Assignee: Nanjing Yanchang Reaction Technology Research Institute Co., Ltd.
    Inventors: Zhibing Zhang, Zheng Zhou, Weimin Meng, Feng Zhang, Lei Li, Baorong Wang, Gaodong Yang, Huaxun Luo, Guoqiang Yang, Hongzhou Tian, Yu Cao
  • Publication number: 20220162216
    Abstract: The present invention discloses compounds of Formula (Ia), and pharmaceutically acceptable salts, thereof: which inhibit coronavirus replication activity. The invention further relates to pharmaceutical compositions comprising a compound of Formula (Ia) or a pharmaceutically acceptable salt thereof, and methods of treating or preventing a coronavirus infection in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a compound of Formula (Ia) or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: September 20, 2021
    Publication date: May 26, 2022
    Inventors: Guoqiang Wang, Ruichao Shen, Yong He, Xuri Gao, Jun Ma, Xuechao Xing, Hui Cao, Joseph D. Panarese, Yat Sun Or
  • Publication number: 20220162217
    Abstract: The present invention discloses compounds of Formula (Ia), and pharmaceutically acceptable salts, thereof: which inhibit coronavirus replication activity. The invention further relates to pharmaceutical compositions comprising a compound of Formula (Ia) or a pharmaceutically acceptable slat thereof, and methods of treating or preventing a coronavirus infection in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a compound of Formula (Ia) or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: September 20, 2021
    Publication date: May 26, 2022
    Inventors: Guoqiang Wang, Xuri Gao, Ruichao Shen, Yong He, Jiajun Zhang, Joseph D. Panarese, Hui Cao, Xuechao Xing, Yat Sun Or
  • Publication number: 20220162231
    Abstract: The present invention discloses compounds of Formula (I), and pharmaceutically acceptable salts, thereof: which inhibit coronavirus replication activity. The invention further relates to pharmaceutical compositions comprising a compound of Formula (I) or a pharmaceutically acceptable salt thereof, and methods of treating or preventing a coronavirus infection in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a compound of Formula (I) or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: November 22, 2021
    Publication date: May 26, 2022
    Inventors: Guoqiang Wang, Ruichao Shen, Jun Ma, Yong He, Xuechao Xing, Hui Cao, Xuri Gao, Xiaowen Peng, Joseph D. Panarese, Yat Sun Or
  • Patent number: 11339170
    Abstract: The present invention discloses compounds of Formula (I), and pharmaceutically acceptable salts, thereof: which inhibit coronavirus replication activity. The invention further relates to pharmaceutical compositions comprising a compound of Formula (I) or a pharmaceutically acceptable salt thereof, and methods of treating or preventing a coronavirus infection in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a compound of Formula (I) or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: September 20, 2021
    Date of Patent: May 24, 2022
    Assignee: Enanta Pharmaceuticals, Inc.
    Inventors: Xuri Gao, Wei Li, Jiajun Zhang, Xiaowen Peng, Hui Cao, Jorden Kass, Ruichao Shen, Guoqiang Wang, Yat Sun Or
  • Patent number: 11332639
    Abstract: The present invention discloses an aqueous antifogging resin, introducing a molecular segment and a functional group with good hydrophilicity and hygroscopicity, which impart excellent antifogging performance, coating strength and transparent flow appearance to the aqueous antifogging resin and the cured coating has a water contact angle of up to 1˜10°. The present invention further discloses a coating composition including the aqueous antifogging resin, and the cured coating of the coating composition has good antifogging, wear-resistant, water-resistant, chemical resistant, stain-resistant and UV-resistant performance, and excellent adhesion to a substrate; and the coating is firm at the same time, and has excellent film-forming strength and flexual endurance. The coating composition can be used for antifogging surface treatment of the window of mobile phone, PC or PMMA transparent materials, automotive glass and bathroom mirrors and has good long-term stability.
    Type: Grant
    Filed: January 23, 2019
    Date of Patent: May 17, 2022
    Assignee: HUNAN SOKAN NEW MATERIALS CO., LTD.
    Inventors: Peikai Miao, Yunjian Ling, Weiguo Wang, Bo Yang, Guoqiang Lv
  • Publication number: 20220148747
    Abstract: Disclosed are a voltage drop measurement system and methods for measuring resistivity of a nuclear reactor cladding. The system includes a short cladding sample of a nuclear reactor cladding. Two electrically conductive plugs are attached to the short cladding. A power supply is electrically coupled to the each of the two electrically conductive plugs and is configured to apply an electrical current to the short cladding through the two electrically conductive plugs. Two needle like probes are electrically coupled to a surface of the short cladding between the two electrically conductive plugs. The needle like probes are spaced apart by a distance L. Resistivity and heat flux are determined in accordance with Equations (1)-(4).
    Type: Application
    Filed: November 10, 2021
    Publication date: May 12, 2022
    Applicant: Westinghouse Electric Company LLC
    Inventors: Guoqiang WANG, William A. BYERS, Stephen J. HARDING, Kevin A. HARDING
  • Patent number: 11325916
    Abstract: The present invention discloses compounds of Formula (I), and pharmaceutically acceptable salts, thereof: which inhibit coronavirus replication activity. The invention further relates to pharmaceutical compositions comprising a compound of Formula (I) or a pharmaceutically acceptable salt thereof, and methods of treating or preventing a coronavirus infection in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a compound of Formula (I) or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: September 20, 2021
    Date of Patent: May 10, 2022
    Assignee: Enanta Pharmaceuticals, Inc.
    Inventors: Ruichao Shen, Yong He, Xuechao Xing, Matthew C. Rhodes, Guoqiang Wang, Yat Sun Or
  • Patent number: 11319325
    Abstract: The present invention discloses compounds of Formula (I), and pharmaceutically acceptable salts, thereof: which inhibit coronavirus replication activity. The invention further relates to pharmaceutical compositions comprising a compound of Formula (I) or a pharmaceutically acceptable salt thereof, and methods of treating or preventing a coronavirus infection in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a compound of Formula (I) or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: September 20, 2021
    Date of Patent: May 3, 2022
    Assignee: Enanta Pharmaceuticals, Inc.
    Inventors: Jiajun Zhang, Xiaowen Peng, Joseph D. Panarese, Guoqiang Wang, Yat Sun Or